Literature DB >> 11090056

Characterization of dendritic cell differentiation pathways from cord blood CD34(+)CD7(+)CD45RA(+) hematopoietic progenitor cells.

B Canque1, S Camus, A Dalloul, E Kahn, M Yagello, C Dezutter-Dambuyant, D Schmitt, C Schmitt, J C Gluckman.   

Abstract

To better characterize human dendritic cells (DCs) that originate from lymphoid progenitors, the authors examined the DC differentiation pathways from a novel CD7(+)CD45RA(+) progenitor population found among cord blood CD34(+) cells. Unlike CD7(-)CD45RA(+) and CD7(+)CD45RA(-) progenitors, this population displayed high natural killer (NK) cell differentiation capacity when cultured with stem cell factor (SCF), interleukin (IL)-2, IL-7, and IL-15, attesting to its lymphoid potential. In cultures with SCF, Flt3 ligand (FL), granulocyte-macrophage colony-stimulating factor (GM-CSF), and tumor necrosis factor (TNF)-alpha (standard condition), CD7(+)CD45RA(+) progenitors expanded less (37- vs 155-fold) but yielded 2-fold higher CD1a(+) DC percentages than CD7(-)CD45RA(+) or CD7(+)CD45RA(-) progenitors. As reported for CD34(+)CD1a(-) thymocytes, cloning experiments demonstrated that CD7(+)CD45RA(+) cells comprised bipotent NK/DC progenitors. DCs differentiated from CD7(-)CD45RA(+) and CD7(+)CD45RA(+) progenitors differed as to E-cadherin CD123, CD116, and CD127 expression, but none of these was really discriminant. Only CD7(+)CD45RA(+) or thymic progenitors differentiated into Lag(+)S100(+) Langerhans cells in the absence of exogenous transforming growth factor (TGF)-beta 1. Analysis of the DC differentiation pathways showed that CD7(+)CD45RA(+) progenitors generated CD1a(+)CD14(-) precursors that were macrophage-colony stimulating factor (M-CSF) resistant and CD1a(-)CD14(+) precursors that readily differentiated into DCs under the standard condition. Accordingly, CD7(+)CD45RA(+) progenitor-derived mature DCs produced 2- to 4-fold more IL-6, IL-12, and TNF-alpha on CD40 ligation and elicited 3- to 6-fold higher allogeneic T-lymphocyte reactivity than CD7(-)CD45RA(+) progenitor-derived DCs. Altogether, these findings provide evidence that the DCs that differentiate from cord blood CD34(+)CD7(+)CD45RA(+) progenitors represent an original population for their developmental pathways and function. (Blood. 2000;96:3748-3756)

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11090056

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

1.  Delta-1 enhances marrow and thymus repopulating ability of human CD34(+)CD38(-) cord blood cells.

Authors:  Kohshi Ohishi; Barbara Varnum-Finney; Irwin D Bernstein
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

2.  Langerhans cells from human oral epithelium are more effective at stimulating allogeneic T cells in vitro than Langerhans cells from skin.

Authors:  B Hasséus; M Jontell; G Bergenholtz; U I Dahlgren
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

3.  Isolation of dendritic cells from umbilical cord blood using magnetic activated cell sorting or adherence.

Authors:  Yachun Bie; Qiuxiang Xu; Zhenyu Zhang
Journal:  Oncol Lett       Date:  2015-05-11       Impact factor: 2.967

4.  Protective effects of human umbilical cord blood stem cell intravitreal transplantation against optic nerve injury in rats.

Authors:  Tantai Zhao; Yunqin Li; Luosheng Tang; Yuehua Li; Fang Fan; Bing Jiang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-03-01       Impact factor: 3.117

5.  AF1q/MLLT11 regulates the emergence of human prothymocytes through cooperative interaction with the Notch signaling pathway.

Authors:  Aude Parcelier; Nesrine Maharzi; Marc Delord; Macarena Robledo-Sarmiento; Elisabeth Nelson; Halima Belakhdar-Mekid; Marika Pla; Klaudia Kuranda; Veronique Parietti; Michele Goodhardt; Nicolas Legrand; Irwin D Bernstein; Jean Claude Gluckman; François Sigaux; Bruno Canque
Journal:  Blood       Date:  2011-06-28       Impact factor: 22.113

6.  Flk2+ myeloid progenitors are the main source of Langerhans cells.

Authors:  Ines Mende; Holger Karsunky; Irving L Weissman; Edgar G Engleman; Miriam Merad
Journal:  Blood       Date:  2005-11-01       Impact factor: 22.113

7.  In-vitro Behavior of Human Umbilical Cord Blood Stem Cells Towards Serum Based Minimal Cytokine Growth Conditions.

Authors:  Santwana Mantri; Praksh Chandra Mohapatra
Journal:  Indian J Clin Biochem       Date:  2013-05-29

8.  Ex vivo development, expansion and in vivo analysis of a novel lineage of dendritic cells from hematopoietic stem cells.

Authors:  Shuhong Han; Yichen Wang; Bei Wang; Ekta Patel; Starlyn Okada; Li-Jun Yang; Jan S Moreb; Lung-Ji Chang
Journal:  J Immune Based Ther Vaccines       Date:  2010-11-24

9.  Human umbilical cord blood mononuclear cells and chorionic plate-derived mesenchymal stem cells promote axon survival in a rat model of optic nerve crush injury.

Authors:  Sokjoong Chung; Seungsoo Rho; Gijin Kim; So-Ra Kim; Kwang-Hyun Baek; Myungseo Kang; Helen Lew
Journal:  Int J Mol Med       Date:  2016-03-17       Impact factor: 4.101

10.  Human skin dendritic cell fate is differentially regulated by the monocyte identity factor Kruppel-like factor 4 during steady state and inflammation.

Authors:  Jennifer Jurkin; Corinna Krump; René Köffel; Christina Fieber; Christopher Schuster; Patrick M Brunner; Izabela Borek; Gregor Eisenwort; Clarice Lim; Jörg Mages; Roland Lang; Wolfgang Bauer; Diana Mechtcheriakova; Anastasia Meshcheryakova; Adelheid Elbe-Bürger; Georg Stingl; Herbert Strobl
Journal:  J Allergy Clin Immunol       Date:  2016-10-11       Impact factor: 10.793

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.